[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  VenkatP [@VenkatP1359](/creator/twitter/VenkatP1359) on x 1126 followers Created: 2025-07-16 18:20:12 UTC I am getting direct messages why $SMMT up It’s not due to AZN deal They just launched a phase III trial metastatic colorectal cancer where we use Bevacizumab (targets VEGF vascular endothelial growth factor) in conjunction with chemotx such as FOLFOX FOLFiRI XELOX XELIRI regimens some triplet regimens Here you are comparing Ivonescimab bispecific vs bevacizumab only targets VEGF Phase II was positive making the phase II reality XXX engagements  **Related Topics** [manat](/topic/manat) [$smmt](/topic/$smmt) [Post Link](https://x.com/VenkatP1359/status/1945549041175085353)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
VenkatP @VenkatP1359 on x 1126 followers
Created: 2025-07-16 18:20:12 UTC
I am getting direct messages why $SMMT up
It’s not due to AZN deal
They just launched a phase III trial metastatic colorectal cancer where we use Bevacizumab (targets VEGF vascular endothelial growth factor) in conjunction with chemotx such as FOLFOX FOLFiRI XELOX XELIRI regimens some triplet regimens
Here you are comparing Ivonescimab bispecific vs bevacizumab only targets VEGF
Phase II was positive making the phase II reality
XXX engagements
/post/tweet::1945549041175085353